Marketing-authorisation holder
Cadiasun Pharma Gmbh
4 medicines in 2 countries, as authorisation holder and marketer.
Medicines
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Sevofluraan Cadiasun 100%, vloeistof voor inhalatiedampVloeistof voor inhalatiedamp | Sevoflurane | Netherlands | Authorised | 2014 |
| LETROZOL CADIASUN 2.5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG2.5 mg · Comprimido recubierto con película | Letrozole | Spain | Withdrawn | 2013 |
| OXALIPLATINO CADIASUN 5 MG/ML POLVO PARA SOLUCIÓN PARA PERFUSIÓN EFG50 mg · Polvo para solución para perfusión | Oxaliplatin | Spain | Withdrawn | 2013 |
| SEVOFLURANO CADIASUN 100% LIQUIDO PARA INHALACION DEL VAPOR EFG100 Porcentaje peso/peso · Líquido para inhalación del vapor | Sevoflurane | Spain | Withdrawn | 2015 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 3 | 0 | 3 | CompaniesAll medicines |
| Netherlands | 1 | 1 | 0 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- AnaestheticsNervous system · ATC N01A
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- cadiasun
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 4
- Countries
- 2
- Roles
- Authorisation holder and marketer